Join us on July 26, 2022 for our next event. We are excited to announce that this event will be in-person! We anticipate 1.00 General CLE credit in Ohio for this event.

Our presenters will be John Luken and Matthew Molloy, both from Dinsmore & Shohl. Mr. Luken and Mr. Molloy will present on recent Supreme Court and Federal Circuit cases that relate to intellectual property law. 

This presentation will give insights and guidance for both litigators and prosecutors. Particularly, Mr. Luken and Mr. Molloy will discuss the practical and legal implications of cases concerning topics such as eligibility under Section 101, written descriptions under Section 112, licensee appellate standing, nexus requirements for secondary considerations, induced infringement, and fair use. 

This event will include 60 minutes of presentation, and the event space will be booked for additional time for informal networking. Lunch will be provided.

The event will take place at:

The Westin Cincinnati, 21 East 5th Street, Tyler Davidson Room

Registration is 

• $30.00 for CincyIP members, 
• free for students and academics, and 
• $50.00 for non-members. 

Payment may be made by check or cash, with checks being made out to CINCYIP.

Register here by July 25th at 5:00 PM.

About the Speakers:

John Luken focuses his practice on patent infringement litigation and appeals, as well as complex commercial and other intellectual property litigation. He has handled patent infringement cases involving a variety of services and products, including commercial forms and related software, software-related business method patents in the printing and financial services industries, metal beverage cans and closures, surface coal mining blasting methods, liquid beverage concentrates and related packaging, automated barge refurbishing methods, service station petroleum equipment, and retail security products.

Matthew Molloy is admitted to practice before the United States Patent and Trademark Office and has extensive experience in the preparation and prosecution of patents in the U.S. and abroad. He manages international patent portfolios and his practice encompasses a variety of technical areas such as chemical/chemical engineering, materials, polymers, petroleum refining, pharmaceuticals, biotechnology, mechanical engineering, software, and business methods.

Join us on June 21, 2022 for our next webinar. We anticipate 1.00 General CLE credit in Ohio for this event. 

Our presenter will be Ted Davis from Kilpatrick Townsend & Stockton LLP. Mr. Davis will present on Trademark and Unfair Competition Law Developments. 

Speaker Ted Davis will discuss developments in trademark and unfair competition law over the trailing twelve months, including: 

• The effective date of most (but not all) of the Trademark Modernization Act;
• Constitutional challenges to the appointment of the TTAB’s administrative law judges;
• Significant opinions addressing the question of liability for infringement arising from the resale of genuine, but altered or diverted goods;
• Ratification of the initial-interest confusion doctrine;
• Judicial disapproval of transparently opportunistic claims of priority;
• Significant opinions from the Trademark Trial and Appeal Board invalidating registrations as fraudulently procured; and
• Ex parte orders from the Acting Director of the USPTO and the Commissioner for Trademarks sanctioning bad actors.

This webinar will be 60 minutes and will share information on the particulars of law governing trademarks and unfair competition.

Register here by June 20th at 5:00 PM.

About the Speaker:

Ted Davis is a partner in the Atlanta office of Kilpatrick Townsend & Stockton LLP, where he has practiced trademark, copyright, false advertising, and unfair competition law since 1990. Outside the office, he has taught as an adjunct professor at the Emory University and the University of Georgia schools of law and has testified before Congress on trade dress and Internet issues. He is a past member of the International Trademark Association’s Board of Directors, a past chair of the American Bar Association Section of Intellectual Property Law, and a past chair of the American Intellectual Property Law Association’s Trademark Law Committee. As a frequent amicus advocate, he has represented INTA, the ABA, and the AIPLA in a number of briefs submitted to the U.S. Supreme Court.

Ted received his undergraduate degree from Davidson College and his law degree from the University of Virginia. He is a member of the Georgia, New York, and District of Columbia bars.

Join us on May 24, 2022 for our next webinar. We anticipate 1.00 General CLE credit in Ohio for this event. 

Our presenter will be Jeremy Cobb from Arnold & Porter. Mr. Cobb will present on Recent Developments in Pharmaceutical Patent Law-Biotherapeutics, Enablement, and Written Description. 

Since the approval of the first antibody therapy in 1986, the focus of drug discovery and development has gradually shifted away from small, well-defined chemical molecules to large, complex therapeutic biologics. Biotherapeutics are now playing an increasingly prominent role in combating diseases like cancer and autoimmune diseases. Recently, the Federal Circuit has issued key opinions that provide guidance as to which patent claims can withstand 35 U.S.C. § 112 enablement or written description challenges. This presentation will provide an analysis of recent Federal Circuit opinions and their implications for biotherapeutic patents going forward.

This webinar will be 60 minutes and will share information on the particulars of law governing patents directed toward pharmaceutical inventions.

Register here by May 20th at 5:00 PM.

About the Speaker:

Jeremy Cobb focuses on patent litigation and matters before the Patent Trial and Appeal Board with an emphasis on small molecule and biological patents. He is a senior associate focused on matters from case inception through trial and appeal. His experience includes arguing motions and claim construction, taking and defending expert and fact depositions, and overseeing case strategy and management. Mr. Cobb also has a deep understanding of pharmaceutical patent practice, including Hatch-Waxman litigation; regulatory exclusivity; patent term extensions; and pharmaceutical life cycle management.

Prior to becoming an attorney, Mr. Cobb designed and developed synthetic routes to active pharmaceutical ingredients and their intermediates at GlaxoSmithKline.